MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice

Kidney International

Volumn 81, Issue 12, 2012, Pages 1199-1211

  Mulay, Shrikant R ^a   Thomasova, Dana ^a   Ryu, Mi ^a   Anders, Hans Joachim ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cell cycle; ischemia reperfusion; oxidative stress; proliferation; regeneration; wound healing

Indexed keywords

MESSENGER RNA; NUTLIN 3; PROTEIN MDM2; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL GROWTH; CELL REGENERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; HEALING; INFLAMMATION; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 84861668569     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.482     Document Type: Article

References (47)

1. Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med 2007; 357: 797-805.
2. Gurtner GC, Werner S, Barrandon Y et al. Wound repair and regeneration. Nature 2008; 453: 314-321. (Pubitemid 351693137)
3. Leemans JC, Stokman G, Claessen N et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005; 115: 2894-2903. (Pubitemid 41434417)
4. Wu H, Chen G, Wyburn KR et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847-2859. (Pubitemid 47529615)
5. Swaminathan S, Griffin MD. First responders: understanding monocytelineage traffic in the acutely injured kidney. Kidney Int 2008; 74: 1509-1511.
6. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 2005; 15: 599-607. (Pubitemid 41619424)
7. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 2004; 66: 480-485. (Pubitemid 38981982)
8. Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 2003; 14(Suppl 1): S55-S61. (Pubitemid 36687041)
9. Yang L, Besschetnova TY, Brooks CR et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16: 535-543 1p following 143.
10. Bussolati B, Hauser PV, Carvalhosa R et al. Contribution of stem cells to kidney repair. Curr Stem Cell Res Ther 2009; 4: 2-8.
11. Humphreys BD, Valerius MT, Kobayashi A et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008; 2: 284-291. (Pubitemid 351298594)
12. Molitoris BA, Dagher PC, Sandoval RM et al. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol 2009; 20: 1754-1764.
13. Imamura R, Isaka Y, Sandoval RM et al. Intravital 2-photon microscopy assessment of renal protection efficacy of siRNA for p53 in experimental rat kidney transplantation models. Cell Transplant 2010; 19: 1659-1670.
14. Kawai H, Wiederschain D, Yuan ZM. Critical contribution of the MDM2 acidic domain to p53 ubiquitination. Mol Cell Biol 2003; 23: 4939-4947. (Pubitemid 36793339)
15. Haupt Y, Maya R, Kazaz A et al. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387: 296-299. (Pubitemid 27220766)
16. Fang S, Jensen JP, Ludwig RL et al. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 2000; 275: 8945-8951. (Pubitemid 30180252)
17. Vazquez A, Bond EE, Levine AJ et al. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 2008; 7: 979-987.
18. Leach FS, Tokino T, Meltzer P et al. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 1993; 53: 2231-2234. (Pubitemid 23156805)
19. Cordon-Cardo C, Latres E, Drobnjak M et al. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994; 54: 794-799. (Pubitemid 24068339)
20. Watanabe T, Hotta T, Ichikawa A et al. The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood 1994; 84: 3158-3165.
21. Vassilev LT, Vu BT, Graves B et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004; 303: 844-888.
22. Shangary S, Qin D, McEachern D et al. Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition. Proc Natl Acad Sci USA 2008; 105: 3933-3938. (Pubitemid 351723502)
23. Shangary S, Wang S. Small-molecule inhibitors of the MDM2-p53 proteinprotein interaction to reactivate p53 function: a novel approach for cancer therapy. Annu Rev Pharmacol Toxicol 2009; 49: 223-241.
24. Zhou L, Fu P, Huang XR et al. Activation of p53 promotes renal injury in acute aristolochic acid nephropathy. J Am Soc Nephrol 2010; 21: 31-41.
25. Homsi E, Mota da Silva Jr S, Machado de Brito S et al. p53-mediated oxidative stress and tubular injury in rats with glycerol-induced acute kidney injury. Am J Nephrol 2011; 33: 49-59.
26. Dagher PC. Apoptosis in ischemic renal injury: roles of GTP depletion and p53. Kidney Int 2004; 66: 506-509. (Pubitemid 38981987)
27. Kelly KJ, Sandoval RM, Dunn KW et al. A novel method to determine specificity and sensitivity of the TUNEL reaction in the quantitation of apoptosis. Am J Physiol Cell Physiol 2003; 284: C1309-C1318. (Pubitemid 36457412)
28. Anders HJ. Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol 2010; 21: 1270-1274.
29. Rock KL, Latz E, Ontiveros F et al. The sterile inflammatory response. Annu Rev Immunol 2010; 28: 321-342.
30. Montes de Oca Luna R, Wagner DS, Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995; 378: 203-206.
31. Wu H, Ma J, Wang P et al. HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol 2010; 21: 1878-1890.
32. Lech M, Avila-Ferrufino A, Allam R et al. Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein. J Immunol 2009; 183: 4109-4118.
33. Lassen S, Lech M, Rommele C et al. Ischemia reperfusion induces IFN regulatory factor 4 in renal dendritic cells, which suppresses postischemic inflammation and prevents acute renal failure. J Immunol 2010; 185: 1976-1983.
34. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140: 805-820.
35. Sanz AB, Sanchez-Nino MD, Ramos AM et al. NF-kappaB in renal inflammation. J Am Soc Nephrol 2010; 21: 1254-1262.
36. Thurman JM. Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol 2007; 123: 7-13. (Pubitemid 46401502)
37. Cao CC, Ding XQ, Ou ZL et al. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 2004; 65: 834-845. (Pubitemid 38251059)
38. Gu L, Findley HW, Zhou M. MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia. Blood 2002; 99: 3367-3375. (Pubitemid 34525318)
39. Liu G, Park YJ, Tsuruta Y et al. p53 Attenuates lipopolysaccharide- induced NF-kappaB activation and acute lung injury. J Immunol 2009; 182: 5063-5071.
40. Marine JC, Francoz S, Maetens M et al. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ 2006; 13: 927-934.
41. Vassilev LT. MDM2 inhibitors for cancer therapy. Trends Mol Med 2007; 13: 23-31. (Pubitemid 46027725)
42. Klein C, Vassilev LT. Targeting the p53-MDM2 interaction to treat cancer. Br J Cancer 2004; 91: 1415-1419. (Pubitemid 39486340)
43. Saif MW, Mehra R. Incidence and management of bevacizumab-related toxicities in colorectal cancer. Expert Opin Drug Saf 2006; 5: 553-566. (Pubitemid 44468452)
44. Payne WG, Naidu DK, Wheeler CK et al. Wound healing in patients with cancer. Eplasty 2008; 8: e9.
45. Thomson AW, Turnquist HR, Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 2009; 9: 324-337.
46. Yamada K, Miwa T, Liu J et al. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 2004; 172: 3869-3875. (Pubitemid 38337974)
47. Sayyed SG, Gaikwad AB, Lichtnekert J et al. Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. Nephrol Dial Transplant 2010; 25: 1811-1817.